07 December 2022
How have you seen the treatment of cancer evolve in the past 20-30 years? In the timeframe that you mentioned there has been...
06 December 2022
As the CEO of a company that has been changing people’s lives for over 100 years, you have quite a fair amount of responsibility...
30 November 2022
You have worked in the biotechnology industry before the world knew it as such – what has changed and what has remained...
25 November 2022
Amicus Therapeutics has a deeply emotional and personal backstory, can you walk us through what prompted you to bring the...
24 November 2022
Which therapeutics areas is Cureline most invested in today and what is the selected approach to target them? For pharma...
22 November 2022
You have been in the industry for more than 30 years, and in Biocom California for more than 20; what are the main ways in...
18 November 2022
The most noticeable feature of Ilmatar is that it handles renewable energy projects from start to finish: why did you think...
17 November 2022
What was the inception of Otary and what role does it play in the larger context of energy transition in Europe? Otary is...
What are investors that come to Sweden normally looking for? Traditionally, Sweden is seen as a collaborative space where...
How has the CDPQ managed to stay ahead of 2030 and 2050 green targets? We started literally the day after COP 21, the...
28 October 2022
10 August 2022
28 January 2022
14 December 2021
22 July 2021
08 July 2021
